Kim Peter S
- SEC CIK
- 0001181180
No open-market purchases or sales filed in the past year.
Current role at each company
- TRDA Entrada Therapeutics, Inc.Directoras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kim Peter S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2025 (view filing) | May 13-14, 2024 | 401 days | Kim Peter SDirector | PPurchase | +50.0K | $14.64 | +$731.8K | +74.2%117.4K after | Amended2 lots |
| May 10, 2024 (view filing) | May 8-9 | 2 days | Kim Peter SDirector | PPurchase | +4.48K | $14.14 | +$63.3K | +7.1%67.4K after | 2 lots |
| Apr 10, 2024 (view filing) | Apr 8 | 2 days | Kim Peter SDirector | PPurchase | +2.60K | $13.57 | +$35.3K | +4.3%62.9K after | |
| Apr 1, 2024 (view filing) | Mar 28 | 4 days | Kim Peter SDirector | PPurchase | +1.51K | $13.75 | +$20.8K | +2.6%60.3K after | |
| Mar 26, 2024 (view filing) | Mar 22-26 | 4 days | Kim Peter SDirector | PPurchase | +9.05K | $13.58 | +$122.9K | +18.2%58.8K after | 3 lots |
| Mar 21, 2024 (view filing) | Mar 19-21 | 2 days | Kim Peter SDirector | PPurchase | +2.73K | $12.81 | +$35.0K | +5.8%49.8K after | 3 lots |